Archives astrazeneca

by in
Entry Author Date Location
New CEO and $80M Later, Syndax Looks Prepped for Second IPO Try 08/24/15 Boston
East Coast Biotech Roundup: Vertex, Biogen, Sarepta, Juno, & More 07/06/15 Boston
XRpro Resurrects Icagen With Buy of Some Pfizer Ion Channel Assets 07/02/15 Boston
AstraZeneca Working with Eolas Therapeutics on Anti-Addiction Drug 06/30/15 San Diego
Flagship CEO on Backing NY Biotech, Moderna, and Investing in a Boom 06/22/15 New York
East Coast Biotech Roundup: Emulate, Pulmatrix, Synergy & More 06/19/15 New York
West Coast Biotech Roundup: Regulus, Ardelyx, Juno, Sangamo & More 06/04/15 San Francisco
ASCO Roundup: Checkpoints, Pushback Against Prices, CAR-T & More 06/02/15 National
West Coast Biotech Roundup: Illumina, Veracyte, Otonomy, Kite & More 05/22/15 San Diego
East Coast Biotech Roundup: NY Bio, Synageva, Kadmon & More 05/08/15 New York
Ex-AstraZeneca Exec to Lead Surface’s “Next-Gen” Immuno-Oncology Plan 05/07/15 Boston
East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More 04/24/15 Boston
West Coast Biotech Roundup: Juno, Genervon, Tekmira, DNANexus & More 04/23/15 Seattle
Blend Therapeutics Taps Former Clinical Data Chief Fromkin As New CEO 04/13/15 Boston
West Coast Biotech Roundup: Juno, Tekmira, True North, aTyr & More 04/10/15 Seattle
Raleigh-Durham Roundup: MaxPoint, Targacept, Frontier Capital, & More 03/09/15 Raleigh Durham
Well-Funded NGM Bio Nabs $200M To Boost Merck’s Metabolic Pipeline 02/23/15 San Francisco
Why Boston Biotech Should Look to London 02/09/15 Boston
West Coast Biotech Roundup: Zymeworks, Lee Hood, Sue Biggins, Nektar 01/22/15 Seattle
It Had to be You: Why Roche Was The Lone Suitor For Foundation 01/16/15 Boston
More Green For Moderna as Merck Makes $50M Equity Grab, mRNA Deal 01/13/15 Boston
Genentech Redux? Roche Buys Majority Stake in Foundation Medicine 01/12/15 Boston
With Massive Venture Round, Moderna Has $450M Reasons to Stay Private 01/05/15 Boston
Famed Geneticist Altshuler Bolts Broad Institute for Vertex 12/15/14 Boston
Clovis Shares Drop Following Release of Cancer-Drug Trial Data 11/19/14 Boulder/Denver
As Rival Sputters, FibroGen Heads to Nasdaq Via $146M IPO 11/14/14 San Francisco
East Coast Biotech Roundup: Intercept, Idera, Inotek, & More 11/07/14 Boston
Struggling Aegerion Diversifies With Fat Disease Drug 11/06/14 Boston
Raleigh-Durham Roundup: Targacept, Chimerix, Red Hat, & More 10/13/14 Raleigh Durham
Smart-Bug Maker Synlogic Nabs $5M From Gates Foundation 10/07/14 Boston
Page 1 of 7 next page »